Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis \(AD\)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02925793
What this trial is testing

Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD)

Who this might be right for
Atopic Dermatitis
DS Biopharma 327
Early research (Phase 1)Study completedNCT06945458
What this trial is testing

Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Kymera Therapeutics, Inc. 22
Early research (Phase 1)Study completedNCT04772885
What this trial is testing

A Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS)

Who this might be right for
Healthy VolunteerAtopic DermatitisHidradenitis Suppurativa
Kymera Therapeutics, Inc. 154
Not applicableStudy completedNCT02226068
What this trial is testing

Photophoresis Versus Ciclosporine in Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
University of Aarhus 20
Testing effectiveness (Phase 2)Looking for participantsNCT06524635
What this trial is testing

Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

Who this might be right for
Hidradenitis SuppurativaAtopic Dermatitis
AbbVie 60
Early research (Phase 1)WithdrawnNCT00389103
What this trial is testing

Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)

Who this might be right for
SmallpoxAtopic Dermatitis
Sanofi Pasteur, a Sanofi Company
Early research (Phase 1)Study completedNCT04056130
What this trial is testing

Single and Multiple Ascending Doses of KBL697 in Healthy Subjects

Who this might be right for
Atopic Dermatitis (AD)
KoBioLabs 36
Post-approval studies (Phase 4)UnknownNCT06465732
What this trial is testing

Efficacy and Safety of Dupilumab in Combination With Tofacitinib in Moderate to Severe Adult AD Patients

Who this might be right for
Atopic Dermatitis
Second Affiliated Hospital, Zhejiang University, School of Medicine 220
Large-scale testing (Phase 3)Study completedNCT03386032
What this trial is testing

8-Week Atopic Dermatitis (AD) Treatment Study

Who this might be right for
Atopic Dermatitis Eczema
Procter and Gamble 65
Post-approval studies (Phase 4)UnknownNCT01781663
What this trial is testing

Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Kamedis Ltd. 56
Large-scale testing (Phase 3)Study completedNCT05899816
What this trial is testing

A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)

Who this might be right for
Atopic DermatitisModerate-to-severe Atopic Dermatitis
Amgen 221
Testing effectiveness (Phase 2)Active Not RecruitingNCT04137562
What this trial is testing

Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
EHL Bio Co., Ltd. 118
Testing effectiveness (Phase 2)Study completedNCT06723405
What this trial is testing

Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)EczemaEczema Atopic Dermatitis
Evommune, Inc. 71
Testing effectiveness (Phase 2)Study completedNCT04893941
What this trial is testing

Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Keymed Biosciences Co.Ltd 39
Testing effectiveness (Phase 2)Ended earlyNCT05491447
What this trial is testing

A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
BioMimetix JV, LLC 103
Not applicableNot Yet RecruitingNCT07270965
What this trial is testing

Moisturization and Skin Hydration Study

Who this might be right for
Atopic Dermatitis (AD)Atopic Dermatitis (Eczema)
University of British Columbia 30
Not applicableLooking for participantsNCT04170244
What this trial is testing

Skin Microbial Ecology in Atopic Dermatitis

Who this might be right for
Atopic DermatitisPsoriasisHealthy
University of Rochester 240
Testing effectiveness (Phase 2)UnknownNCT02365246
What this trial is testing

Treatment of AD With IgE Specific Immunoadsorption (IGEIAAD)

Who this might be right for
Atopic Dermatitis
Universitaire Ziekenhuizen KU Leuven 15
Early research (Phase 1)Active Not RecruitingNCT06920693
What this trial is testing

Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy Adult Participants

Who this might be right for
Atopic Dermatitis (AD)
Generate Biomedicines 40
Large-scale testing (Phase 3)Study completedNCT02755649
What this trial is testing

Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically Advisable

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 325
Next Page